Tapewire

Nasdaq · USD

KURA

Kura Oncology, Inc.

Export transactions ↓
Tapewire entity
4871
SEC CIK
0001422143
Parsed reports
239

Last 12 months

Inside the activity.

2 purchase rows · 31 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202505
Dec 202502
Jan 2026016
Feb 202600
Mar 202600
Apr 202600
May 202604
Jun 202601
Jul 202600
Aug 202622
Sep 202601
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
January 02, 2026 Filed Jan 6, 2026 21:30 UTC
Powl Brian T.Chief Commercial Officer
GrantOption to purchase common stock · Derivative 100,000 $0.00 Strike: $10.34 $0.00
Disclosure

SEC source: 0001193125-26-004564 · ownership.xml · derivative · entry 2

Powl Brian T. · CIK 0001934232 · Chief Commercial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 100,000

Underlying: Common Stock · 100,000 shares

Expires 2036-01-01

F2 · derivative.exercise_date: This option vests in 48 equal monthly installments commencing on the grant date.

Read SEC document
January 02, 2026 Filed Jan 6, 2026 21:30 UTC
Powl Brian T.Chief Commercial Officer
GrantCommon Stock 50,000 $0.00 $0.00
Disclosure

SEC source: 0001193125-26-004564 · ownership.xml · nonDerivative · entry 1

Powl Brian T. · CIK 0001934232 · Chief Commercial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 189,689

F1 · shares: Grant of Restricted Stock Units (RSUs). The RSUs vest in four equal annual installments on 1/26/27, 1/26/28, 1/26/29 and 1/26/30.

Read SEC document
December 18, 2025 Filed Dec 19, 2025 16:30 UTC
Burrows FrancisChief Scientific Officer
Exercise / conversionStock Option (Right to Buy) · Derivative 35,000 $0.00 Strike: $4.80 $0.00
Disclosure

SEC source: 0001193125-25-326948 · ownership.xml · derivative · entry 3

Burrows Francis · CIK 0002051119 · Chief Scientific Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common stock · 35,000 shares

Expires 2026-01-29

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Cashless exercise and sale of a portion of a stock option to cover estimated payroll tax liability.

F4 · derivative.exercise_date: This option is fully vested.

Read SEC document
December 18, 2025 Filed Dec 19, 2025 16:30 UTC
Burrows FrancisChief Scientific Officer
SaleCommon Stock 23,726 $9.78 $231,931.14
Disclosure

SEC source: 0001193125-25-326948 · ownership.xml · nonDerivative · entry 2

Burrows Francis · CIK 0002051119 · Chief Scientific Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 33,735

F3 · price: This transaction was executed in multiple trades at prices ranging from $9.77 to $9.82. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
December 18, 2025 Filed Dec 19, 2025 16:30 UTC
Burrows FrancisChief Scientific Officer
Exercise / conversionCommon Stock 35,000 $4.80 $168,000.00
Disclosure

SEC source: 0001193125-25-326948 · ownership.xml · nonDerivative · entry 1

Burrows Francis · CIK 0002051119 · Chief Scientific Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 57,461

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Cashless exercise and sale of a portion of a stock option to cover estimated payroll tax liability.

F2 · balance_after: Includes 857 shares acquired on May 17, 2025 and 899 shares acquired on November 17, 2025 pursuant to the Issuer's Employee Stock Purchase Plan.

Read SEC document
December 09, 2025 Filed Dec 10, 2025 21:05 UTC SaleCommon Stock 10,000 $10.98 $109,764.00
Disclosure

SEC source: 0001193125-25-314154 · ownership.xml · nonDerivative · entry 2

Hasnain Faheem · CIK 0001352620 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 23,983

F1 · kind: The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 8, 2025.

F2 · price: This transaction was executed in multiple trades at prices ranging from $10.60 to $11.53. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
December 09, 2025 Filed Dec 10, 2025 21:05 UTC Exercise / conversionCommon Stock 10,000 $3.12 $31,200.00
Disclosure

SEC source: 0001193125-25-314154 · ownership.xml · nonDerivative · entry 1

Hasnain Faheem · CIK 0001352620 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 33,983

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 8, 2025.

Read SEC document
November 14, 2025 Filed Nov 15, 2025 01:00 UTC
Leoni MollieChief Medical Officer
SaleCommon Stock 15,485 $11.18 $173,074.30
Disclosure

SEC source: 0001193125-25-283563 · ownership.xml · nonDerivative · entry 2

Leoni Mollie · CIK 0002051106 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 225,454

F1 · kind: Sell-to-cover for taxes associated with the vesting of 1/6th of the underlying shares of performance-based restricted stock units ("PSUs") granted to the Reporting Person on May 31, 2023 and January 2, 2025. Each PSU represents the contingent right to receive one share of the Issuer's common stock based on the achievement of each of three specified development milestones, and the one-year anniversary of each milestone achievement, subject to the Reporting Person's continuous service on each corresponding vesting date. The performance criteria for one specified development milestone was determined to be met on November 13, 2025, resulting in the vesting of 1/6th of the underlying shares.

Read SEC document
November 14, 2025 Filed Nov 15, 2025 01:00 UTC
Bair Teresa BrophyChief Legal Officer
SaleCommon Stock 8,804 $11.18 $98,401.43
Disclosure

SEC source: 0001193125-25-283568 · ownership.xml · nonDerivative · entry 2

Bair Teresa Brophy · CIK 0001813058 · Chief Legal Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 188,139

F1 · kind: Sell-to-cover for taxes associated with the vesting of 1/6th of the underlying shares of performance-based restricted stock units ("PSUs") granted to the Reporting Person on May 31, 2023. Each PSU represents the contingent right to receive one share of the Issuer's common stock based on the achievement of each of three specified development milestones, and the one-year anniversary of each milestone achievement, subject to the Reporting Person's continuous service on each corresponding vesting date. The performance criteria for one specified development milestone was determined to be met on November 13, 2025, resulting in the vesting of 1/6th of the underlying shares.

Read SEC document
November 14, 2025 Filed Nov 15, 2025 01:00 UTC
Powl Brian T.Chief Commercial Officer
SaleCommon Stock 8,887 $11.18 $99,329.11
Disclosure

SEC source: 0001193125-25-283564 · ownership.xml · nonDerivative · entry 2

Powl Brian T. · CIK 0001934232 · Chief Commercial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 139,689

F2 · kind: Sell-to cover for taxes associated with the vesting of an RSU received by the Reporting Person dated 11/13/25.

Read SEC document
November 14, 2025 Filed Nov 15, 2025 01:00 UTC
FORD KATHLEENChief Operating Officer
SaleCommon Stock 6,902 $11.18 $77,142.96
Disclosure

SEC source: 0001193125-25-283560 · ownership.xml · nonDerivative · entry 2

FORD KATHLEEN · CIK 0001785406 · Chief Operating Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 105,373

F1 · kind: Sell-to-cover for taxes associated with the vesting of 1/6th of the underlying shares of performance-based restricted stock units ("PSUs") granted to the Reporting Person on May 31, 2023. Each PSU represents the contingent right to receive one share of the Issuer's common stock based on the achievement of each of three specified development milestones, and the one-year anniversary of each milestone achievement, subject to the Reporting Person's continuous service on each corresponding vesting date. The performance criteria for one specified development milestone was determined to be met on November 13, 2025, resulting in the vesting of 1/6th of the underlying shares.

Read SEC document
November 14, 2025 Filed Nov 15, 2025 01:00 UTC
DOYLE THOMAS JAMESSVP, Finance & Accounting
SaleCommon Stock 4,539 $11.18 $50,731.95
Disclosure

SEC source: 0001193125-25-283562 · ownership.xml · nonDerivative · entry 2

DOYLE THOMAS JAMES · CIK 0001910331 · SVP, Finance & Accounting

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 130,257

F1 · kind: Sell-to-cover for taxes associated with the vesting of 1/6th of the underlying shares of performance-based restricted stock units ("PSUs") granted to the Reporting Person on May 31, 2023. Each PSU represents the contingent right to receive one share of the Issuer's common stock based on the achievement of each of three specified development milestones, and the one-year anniversary of each milestone achievement, subject to the Reporting Person's continuous service on each corresponding vesting date. The performance criteria for one specified development milestone was determined to be met on November 13, 2025, resulting in the vesting of 1/6th of the underlying shares.

Read SEC document
November 13, 2025 Filed Nov 15, 2025 01:00 UTC
Leoni MollieChief Medical Officer
GrantCommon Stock 82,500 $0.00 $0.00
Disclosure

SEC source: 0001193125-25-283563 · ownership.xml · nonDerivative · entry 1

Leoni Mollie · CIK 0002051106 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 240,939

Read SEC document
November 13, 2025 Filed Nov 15, 2025 01:00 UTC
Bair Teresa BrophyChief Legal Officer
GrantCommon Stock 48,900 $0.00 $0.00
Disclosure

SEC source: 0001193125-25-283568 · ownership.xml · nonDerivative · entry 1

Bair Teresa Brophy · CIK 0001813058 · Chief Legal Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 196,943

Read SEC document
November 13, 2025 Filed Nov 15, 2025 01:00 UTC
WILSON TROY EDWARDDirector · President and CEO
GrantCommon Stock 182,500 $0.00 $0.00
Disclosure

SEC source: 0001193125-25-283565 · ownership.xml · nonDerivative · entry 1

WILSON TROY EDWARD · CIK 0001589597 · Director · President and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 429,353

F1 · kind: Represents 1/3rd of the underlying shares of performance-based restricted stock units ("PSUs") granted to the Reporting Person on May 31, 2023. Each PSU represents the contingent right to receive one share of the Issuer's common stock based on the achievement of each of three specified development milestones, and the one-year anniversary of each milestone achievement, subject to the Reporting Person's continuous service on each corresponding vesting date. The performance criteria for one specified development milestone was determined to be met on November 13, 2025, resulting in the vesting of 1/6th of the underlying shares.

Read SEC document
November 13, 2025 Filed Nov 15, 2025 01:00 UTC
Powl Brian T.Chief Commercial Officer
GrantCommon Stock 48,900 $0.00 $0.00
Disclosure

SEC source: 0001193125-25-283564 · ownership.xml · nonDerivative · entry 1

Powl Brian T. · CIK 0001934232 · Chief Commercial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 148,576

F1 · shares: Grant of Restricted Stock Units (RSUs). The RSUs vest 50% immediately and 50% on 11/13/26.

Read SEC document
November 13, 2025 Filed Nov 15, 2025 01:00 UTC
FORD KATHLEENChief Operating Officer
GrantCommon Stock 48,900 $0.00 $0.00
Disclosure

SEC source: 0001193125-25-283560 · ownership.xml · nonDerivative · entry 1

FORD KATHLEEN · CIK 0001785406 · Chief Operating Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 112,275

Read SEC document
November 13, 2025 Filed Nov 15, 2025 01:00 UTC
DOYLE THOMAS JAMESSVP, Finance & Accounting
GrantCommon Stock 24,967 $0.00 $0.00
Disclosure

SEC source: 0001193125-25-283562 · ownership.xml · nonDerivative · entry 1

DOYLE THOMAS JAMES · CIK 0001910331 · SVP, Finance & Accounting

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 134,796

Read SEC document
September 29, 2025 Filed Sep 29, 2025 23:30 UTC
Leoni MollieChief Medical Officer
SaleCommon Stock 12,314 $8.94 $110,114.25
Disclosure

SEC source: 0001193125-25-223664 · ownership.xml · nonDerivative · entry 2

Leoni Mollie · CIK 0002051106 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 158,439

F1 · kind: Sell-to-cover for taxes associated with the vesting of 1/6th of the underlying shares of performance-based restricted stock units ("PSUs") granted to the Reporting Person on May 31, 2023 and January 2, 2025. Each PSU represents the contingent right to receive one share of the Issuer's common stock based on the achievement of each of three specified development milestones, and the one-year anniversary of each milestone achievement, subject to the Reporting Person's continuous service on each corresponding vesting date. The performance criteria for one specified development milestone was determined to be met on September 27, 2025, resulting in the vesting of 1/6th of the underlying shares.

Read SEC document
September 29, 2025 Filed Sep 29, 2025 23:30 UTC
Bair Teresa BrophyChief Legal Officer
SaleCommon Stock 8,805 $8.94 $78,736.07
Disclosure

SEC source: 0001193125-25-223666 · ownership.xml · nonDerivative · entry 2

Bair Teresa Brophy · CIK 0001813058 · Chief Legal Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 148,043

F1 · kind: Sell-to-cover for taxes associated with the vesting of 1/6th of the underlying shares of performance-based restricted stock units ("PSUs") granted to the Reporting Person on May 31, 2023. Each PSU represents the contingent right to receive one share of the Issuer's common stock based on the achievement of each of three specified development milestones, and the one-year anniversary of each milestone achievement, subject to the Reporting Person's continuous service on each corresponding vesting date. The performance criteria for one specified development milestone was determined to be met on September 27, 2025, resulting in the vesting of 1/6th of the underlying shares.

Read SEC document
September 29, 2025 Filed Sep 29, 2025 23:30 UTC
Powl Brian T.Chief Commercial Officer
SaleCommon Stock 8,891 $8.94 $79,505.10
Disclosure

SEC source: 0001193125-25-223667 · ownership.xml · nonDerivative · entry 2

Powl Brian T. · CIK 0001934232 · Chief Commercial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 99,676

F1 · kind: Sell-to cover for taxes associated with the vesting of an RSU received by the Reporting Person dated 9/27/25.

Read SEC document
September 29, 2025 Filed Sep 29, 2025 23:30 UTC
FORD KATHLEENChief Operating Officer
SaleCommon Stock 6,892 $8.94 $61,629.64
Disclosure

SEC source: 0001193125-25-223665 · ownership.xml · nonDerivative · entry 2

FORD KATHLEEN · CIK 0001785406 · Chief Operating Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 63,375

F1 · kind: Sell-to-cover for taxes associated with the vesting of 1/6th of the underlying shares of performance-based restricted stock units ("PSUs") granted to the Reporting Person on May 31, 2023. Each PSU represents the contingent right to receive one share of the Issuer's common stock based on the achievement of each of three specified development milestones, and the one-year anniversary of each milestone achievement, subject to the Reporting Person's continuous service on each corresponding vesting date. The performance criteria for one specified development milestone was determined to be met on September 27, 2025, resulting in the vesting of 1/6th of the underlying shares.

Read SEC document
September 29, 2025 Filed Sep 29, 2025 23:30 UTC
WILSON TROY EDWARDDirector · President and CEO
SaleCommon Stock 36,615 $8.94 $327,418.65
Disclosure

SEC source: 0001193125-25-223663 · ownership.xml · nonDerivative · entry 2

WILSON TROY EDWARD · CIK 0001589597 · Director · President and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 246,853

F1 · kind: Sell-to-cover for taxes associated with the vesting of 1/6th of the underlying shares of performance-based restricted stock units ("PSUs") granted to the Reporting Person on May 31, 2023. Each PSU represents the contingent right to receive one share of the Issuer's common stock based on the achievement of each of three specified development milestones, and the one-year anniversary of each milestone achievement, subject to the Reporting Person's continuous service on each corresponding vesting date. The performance criteria for one specified development milestone was determined to be met on September 27, 2025, resulting in the vesting of 1/6th of the underlying shares.

Read SEC document
September 29, 2025 Filed Sep 29, 2025 23:30 UTC
DOYLE THOMAS JAMESSVP, Finance & Accounting
SaleCommon Stock 4,541 $8.94 $40,606.53
Disclosure

SEC source: 0001193125-25-223662 · ownership.xml · nonDerivative · entry 2

DOYLE THOMAS JAMES · CIK 0001910331 · SVP, Finance & Accounting

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 109,829

F2 · kind: Sell-to-cover for taxes associated with the vesting of 1/6th of the underlying shares of performance-based restricted stock units ("PSUs") granted to the Reporting Person on May 31, 2023. Each PSU represents the contingent right to receive one share of the Issuer's common stock based on the achievement of each of three specified development milestones, and the one-year anniversary of each milestone achievement, subject to the Reporting Person's continuous service on each corresponding vesting date. The performance criteria for one specified development milestone was determined to be met on September 27, 2025, resulting in the vesting of 1/6th of the underlying shares.

Read SEC document
September 27, 2025 Filed Sep 29, 2025 23:30 UTC
Leoni MollieChief Medical Officer
GrantCommon Stock 82,500 $0.00 $0.00
Disclosure

SEC source: 0001193125-25-223664 · ownership.xml · nonDerivative · entry 1

Leoni Mollie · CIK 0002051106 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 170,753

Read SEC document
September 27, 2025 Filed Sep 29, 2025 23:30 UTC
Bair Teresa BrophyChief Legal Officer
GrantCommon Stock 48,900 $0.00 $0.00
Disclosure

SEC source: 0001193125-25-223666 · ownership.xml · nonDerivative · entry 1

Bair Teresa Brophy · CIK 0001813058 · Chief Legal Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 156,848

Read SEC document
September 27, 2025 Filed Sep 29, 2025 23:30 UTC
Powl Brian T.Chief Commercial Officer
GrantCommon Stock 48,900 $0.00 $0.00
Disclosure

SEC source: 0001193125-25-223667 · ownership.xml · nonDerivative · entry 1

Powl Brian T. · CIK 0001934232 · Chief Commercial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 108,567

Read SEC document
September 27, 2025 Filed Sep 29, 2025 23:30 UTC
FORD KATHLEENChief Operating Officer
GrantCommon Stock 48,900 $0.00 $0.00
Disclosure

SEC source: 0001193125-25-223665 · ownership.xml · nonDerivative · entry 1

FORD KATHLEEN · CIK 0001785406 · Chief Operating Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 70,267

Read SEC document
September 27, 2025 Filed Sep 29, 2025 23:30 UTC
WILSON TROY EDWARDDirector · President and CEO
GrantCommon Stock 182,500 $0.00 $0.00
Disclosure

SEC source: 0001193125-25-223663 · ownership.xml · nonDerivative · entry 1

WILSON TROY EDWARD · CIK 0001589597 · Director · President and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 283,468

Read SEC document
September 27, 2025 Filed Sep 29, 2025 23:30 UTC
DOYLE THOMAS JAMESSVP, Finance & Accounting
GrantCommon Stock 24,966 $0.00 $0.00
Disclosure

SEC source: 0001193125-25-223662 · ownership.xml · nonDerivative · entry 1

DOYLE THOMAS JAMES · CIK 0001910331 · SVP, Finance & Accounting

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 114,370

F1 · balance_after: Includes 1,211 shares acquired on May 17, 2025 pursuant to the Issuer's Employee Stock Purchase Plan.

Read SEC document
September 08, 2025 Filed Sep 9, 2025 20:28 UTC
WILSON TROY EDWARDDirector · President & CEO
PurchaseCommon Stock 50,000 $8.20 $410,145.00
Disclosure

SEC source: 0001415889-25-023974 · form4-09092025_080937.xml · nonDerivative · entry 1

WILSON TROY EDWARD · CIK 0001589597 · Director · President & CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 100,968

F1 · price: This transaction was executed in multiple trades at prices ranging from $8.135 to $8.24. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakesto provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
August 13, 2025 Filed Aug 14, 2025 20:05 UTC
WILSON TROY EDWARDDirector · President and CEO
PurchaseCommon Stock 13,494 $6.64 $89,623.10
Disclosure

SEC source: 0000950170-25-108844 · ownership.xml · nonDerivative · entry 2

WILSON TROY EDWARD · CIK 0001589597 · Director · President and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 50,968

F3 · price: This transaction was executed in multiple trades at prices ranging from $6.485 to $6.735. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
August 12, 2025 Filed Aug 14, 2025 20:05 UTC
WILSON TROY EDWARDDirector · President and CEO
PurchaseCommon Stock 36,506 $5.85 $213,578.35
Disclosure

SEC source: 0000950170-25-108844 · ownership.xml · nonDerivative · entry 1

WILSON TROY EDWARD · CIK 0001589597 · Director · President and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 37,474

F1 · price: This transaction was executed in multiple trades at prices ranging from $5.56 to $5.995. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

F2 · balance_after: Includes 409 shares acquired on May 17, 2024 pursuant to the Issuer's Employee Stock Purchase Plan.

Read SEC document
June 05, 2025 Filed Jun 6, 2025 20:05 UTC GrantOption to purchase common stock · Derivative 28,500 $0.00 Strike: $6.57 $0.00
Disclosure

SEC source: 0000950170-25-083040 · ownership.xml · derivative · entry 1

Parks Diane L. · CIK 0001781026 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 28,500

Underlying: Common Stock · 28,500 shares

Expires 2035-06-04

F1 · derivative.exercise_date: This option vests in full on the one year anniversary of the date of grant.

Read SEC document
June 05, 2025 Filed Jun 6, 2025 20:05 UTC GrantOption to purchase common stock · Derivative 28,500 $0.00 Strike: $6.57 $0.00
Disclosure

SEC source: 0000950170-25-083041 · ownership.xml · derivative · entry 1

Collins Helen Louise · CIK 0001701247 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 28,500

Underlying: Common Stock · 28,500 shares

Expires 2035-06-04

F1 · derivative.exercise_date: This option vests in full on the one year anniversary of the date of grant.

Read SEC document
June 05, 2025 Filed Jun 6, 2025 20:05 UTC GrantOption to purchase common stock · Derivative 28,500 $0.00 Strike: $6.57 $0.00
Disclosure

SEC source: 0000950170-25-083038 · ownership.xml · derivative · entry 1

SCHAFER CAROL · CIK 0001272181 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 28,500

Underlying: Common Stock · 28,500 shares

Expires 2035-06-04

F1 · derivative.exercise_date: This option vests in full on the one year anniversary of the date of grant.

Read SEC document
June 05, 2025 Filed Jun 6, 2025 20:05 UTC GrantOption to purchase common stock · Derivative 28,500 $0.00 Strike: $6.57 $0.00
Disclosure

SEC source: 0000950170-25-083037 · ownership.xml · derivative · entry 1

VASCONCELLES MICHAEL · CIK 0001734755 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 28,500

Underlying: Common Stock · 28,500 shares

Expires 2035-06-04

F1 · derivative.exercise_date: This option vests in full on the one year anniversary of the date of grant.

Read SEC document
June 05, 2025 Filed Jun 6, 2025 20:05 UTC GrantOption to purchase common stock · Derivative 28,500 $0.00 Strike: $6.57 $0.00
Disclosure

SEC source: 0000950170-25-083039 · ownership.xml · derivative · entry 1

Hasnain Faheem · CIK 0001352620 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 28,500

Underlying: Common Stock · 28,500 shares

Expires 2035-06-04

F1 · derivative.exercise_date: This option vests in full on the one year anniversary of the date of grant.

Read SEC document
June 05, 2025 Filed Jun 6, 2025 20:05 UTC GrantOption to purchase common stock · Derivative 28,500 $0.00 Strike: $6.57 $0.00
Disclosure

SEC source: 0000950170-25-083036 · ownership.xml · derivative · entry 1

Malley Thomas · CIK 0001403322 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 28,500

Underlying: Common Stock · 28,500 shares

Expires 2035-06-04

F1 · derivative.exercise_date: This option vests in full on the one year anniversary of the date of grant.

Read SEC document
June 05, 2025 Filed Jun 6, 2025 20:05 UTC
Szela Mary TDirector
GrantOption to purchase common stock · Derivative 28,500 $0.00 Strike: $6.57 $0.00
Disclosure

SEC source: 0000950170-25-083035 · ownership.xml · derivative · entry 1

Szela Mary T · CIK 0001410289 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 28,500

Underlying: Common Stock · 28,500 shares

Expires 2035-06-04

F1 · derivative.exercise_date: This option vests in full on the one year anniversary of the date of grant.

Read SEC document
May 19, 2025 Filed May 19, 2025 22:30 UTC
Bair Teresa BrophyChief Legal Officer
SaleCommon Stock 1,559 $5.96 $9,291.64
Disclosure

SEC source: 0000950170-25-074660 · ownership.xml · nonDerivative · entry 1

Bair Teresa Brophy · CIK 0001813058 · Chief Legal Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 107,948

F1 · kind: The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 31, 2024.

F2 · shares: 1,559 shares were acquired on May 17, 2025 pursuant to the Issuer's Employee Stock Purchase Plan.

Read SEC document
May 19, 2025 Filed May 19, 2025 22:30 UTC
FORD KATHLEENChief Operating Officer
SaleCommon Stock 1,558 $6.28 $9,777.38
Disclosure

SEC source: 0000950170-25-074659 · ownership.xml · nonDerivative · entry 1

FORD KATHLEEN · CIK 0001785406 · Chief Operating Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 21,367

F1 · kind: The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 10, 2024.

F2 · shares: 1,558 shares were acquired on May 17, 2025 pursuant to the Issuer's Employee Stock Purchase Plan.

F3 · price: This transaction was executed in multiple trades at prices ranging from $6.27 to $6.28. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
March 21, 2025 Filed Mar 24, 2025 20:33 UTC SaleCommon Stock 22,682 $8.00 $181,456.00
Disclosure

SEC source: 0000950170-25-043903 · ownership.xml · nonDerivative · entry 2

Hasnain Faheem · CIK 0001352620 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 23,983

F1 · kind: The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 20, 2024.

F2 · price: This transaction was executed in multiple trades at prices ranging from $8.00 to $8.03. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
March 21, 2025 Filed Mar 24, 2025 20:33 UTC Exercise / conversionCommon Stock 22,682 $6.32 $143,350.24
Disclosure

SEC source: 0000950170-25-043903 · ownership.xml · nonDerivative · entry 1

Hasnain Faheem · CIK 0001352620 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 46,665

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 20, 2024.

Read SEC document
January 28, 2025 Filed Jan 29, 2025 01:39 UTC
Leoni MollieChief Medical Officer
SaleCommon Stock 541 $7.87 $4,258.70
Disclosure

SEC source: 0000950170-25-010121 · ownership.xml · nonDerivative · entry 4

Leoni Mollie · CIK 0002051106 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 88,253

F4 · acquired: Sell-to cover for taxes associated with the vesting of an RSU received by the Reporting Person dated 1/26/21.

Read SEC document
January 28, 2025 Filed Jan 29, 2025 01:39 UTC
Leoni MollieChief Medical Officer
SaleCommon Stock 816 $7.87 $6,423.47
Disclosure

SEC source: 0000950170-25-010121 · ownership.xml · nonDerivative · entry 3

Leoni Mollie · CIK 0002051106 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 88,794

F3 · acquired: Sell-to cover for taxes associated with the vesting of an RSU received by the Reporting Person dated 2/16/23.

Read SEC document
January 28, 2025 Filed Jan 29, 2025 01:39 UTC
Leoni MollieChief Medical Officer
SaleCommon Stock 1,353 $7.87 $10,650.68
Disclosure

SEC source: 0000950170-25-010121 · ownership.xml · nonDerivative · entry 2

Leoni Mollie · CIK 0002051106 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 89,610

F2 · acquired: Sell-to cover for taxes associated with the vesting of an RSU received by the Reporting Person dated 1/26/22.

Read SEC document
January 28, 2025 Filed Jan 29, 2025 01:39 UTC
Leoni MollieChief Medical Officer
SaleCommon Stock 2,253 $7.87 $17,735.39
Disclosure

SEC source: 0000950170-25-010121 · ownership.xml · nonDerivative · entry 1

Leoni Mollie · CIK 0002051106 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 90,963

F1 · acquired: Sell-to cover for taxes associated with the vesting of an RSU received by the Reporting Person dated 1/2/24.

Read SEC document
January 28, 2025 Filed Jan 28, 2025 20:38 UTC
Burrows FrancisChief Scientific Officer
SaleCommon Stock 1,320 $7.87 $10,390.91
Disclosure

SEC source: 0000950170-25-010117 · ownership.xml · nonDerivative · entry 2

Burrows Francis · CIK 0002051119 · Chief Scientific Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 20,705

F2 · acquired: Sell-to cover for taxes associated with the vesting of an RSU received by the Reporting Person dated 1/26/22.

Read SEC document
January 28, 2025 Filed Jan 28, 2025 20:38 UTC
Burrows FrancisChief Scientific Officer
SaleCommon Stock 846 $7.87 $6,659.63
Disclosure

SEC source: 0000950170-25-010117 · ownership.xml · nonDerivative · entry 1

Burrows Francis · CIK 0002051119 · Chief Scientific Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 22,025

F1 · acquired: Sell-to cover for taxes associated with the vesting of an RSU received by the Reporting Person dated 1/26/21.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.